Emergency Medicine by Alexandros G. Sfakianakis
Πληροφορίες
Alexandros G. Sfakianakis
Προβολή πλήρους προφίλ
Τρίτη 25 Ιουνίου 2019
TCT Magazine | 3D Printer & 3D Printing News | Additive Manufacturing | Product Development Technology
Polymaker releases two fibre-reinforced Nylon PA6 3D printing materials
Polymaker has announced the release of two new 3D printing materials, a carbon fibre-reinforced PA6 and a glass fibre-filled PA6.
TCT UK Service Provider Map 2019
A guide to 3D Printing and Additive Manufacturing Service Providers in the UK
Alexandros Sfakianakis
Anapafseos 5 . Agios Nikolaos
Crete.Greece.72100
2841026182
6948891480
alsfakia@gmail.com
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Νεότερη ανάρτηση
Παλαιότερη Ανάρτηση
Αρχική σελίδα
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
Photoacoustic (532 nm & 1064 nm) & ultrasonic co‐scanning microscopy for in vivo imaging on small animals—a productized strategy
...
Ravulizumab: First Global Approval
Abstract Ravulizumab (ravulizumab-cwvz; ULTOMIRIS™), a humanized monoclonal antibody, is a complement C5 inhibitor developed by Alexion Ph...
Dauerhafte Hautstraffung bei Cellulite
http://bit.ly/2TO0eLw
Long‐term impact of patients' compliance to peri‐implant maintenance therapy on the incidence of peri‐implant diseases: An 11‐year prospective follow‐up clinical study
...
Differences between primary and secondary definitive osteosynthesis for fractures of the lower leg with concomitant acute compartment syndrome
Abstract Purpose To analyze the differences in outcomes between primary and secondary definitive osteosynthesis for fractures of the lower...
Chemoprevention with Somatuline© Delays the Progression of Pancreatic Neuroendocrine Neoplasms in a Mouse Model of Multiple Endocrine Neoplasia Type 1 (MEN1)
Abstract Objective Long-acting synthetic somatostatin analogues (SSA) are an essential part of the treatment of neuroendocrine neoplasms...
Monoclonal antibodies against IL-5 or IL-5 receptor alpha (mepolizumab, reslizumab, benralizumab), IL-13 (lebrikizumab, tralokinumab), IL-4 receptor alpha (dupilumab), Immune globuline E (IgE) (omalizumab), anti-Thymic Stromal Lymphopoitin (TSLP) (tezepelumab) and small molecule therapies such as prostaglandin D2 blockers (fevipiprant, timapiprant). New Anti-Eosinophil Drugs for asthma and COPD
http://sfaki.blogspot.com/2017/06/monoclonal-antibodies-against-il-5-or.html Alexandros Sfakianakis Anapafseos 5 . Agios Nikolaos Crete.Gree...
Examining the effect of 5-HTTLPR on depressive symptoms in postmenopausal women 1 year after initial breast cancer treatment
Abstract Background Depression following the diagnosis of breast cancer has been well documented, and occurs in as many as 40% of women....
No call no show no thank you: EMS agency cracks down on flaky employees
CHARLOTTE HALL, Md. — EMS job seekers are given specific reasons to not apply for a position in a job posting for paramedics, EMTs and dispa...
Automated T2-mapping of the menisci from magnetic resonance images in patients with acute knee injury
Academic Radiology from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2t1H331
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου